Supernus Pharmaceuticals Inc (SUPN) News | Morningstar Mar 18, 2020 · SUPN Morningstar Rating Rating as of Mar 18, 2020. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Supernus Pharmaceuticals Stock Quote. SUPN - Stock Price ... Supernus Pharmaceuticals stock quote and SUPN charts. Latest stock price today and the US's most active stock market forums. Supernus Pharmaceuticals (SUPN) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Supernus Pharmaceuticals Stock Forecast: down to 1.087 USD ... Historical index on US Stock Market : A+ "Should I invest in Supernus Pharmaceuticals stock?" "Should I trade "SUPN" stock today?" According to our live Forecast System, Supernus Pharmaceuticals, Inc stock is a bad long-term (1-year) investment*. "SUPN" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.
SUPN - Supernus Pharmaceuticals, Inc. Summary, Stock Quote ...
Supernus Pharmaceuticals Inc : SUPN Stock Price Quote at ... Free current stock price quotes and data for Supernus Pharmaceuticals Inc (SUPN). Research news, charts, stock market performance and earnings. SUPN Stock News - Fidelity Mar 27, 2020 · ROCKVILLE, Md., Feb. 25, 2020 -- Supernus Pharmaceuticals, Inc. (SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today reported financial results for the fourth quarter and full year of 2019, and associated Company developments. Supernus Pharmaceuticals Inc (SUPN) News | Morningstar Mar 18, 2020 · SUPN Morningstar Rating Rating as of Mar 18, 2020. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership
Real time Supernus Pharmaceuticals (SUPN) stock price quote, stock graph, news & analysis. Real time Supernus Pharmaceuticals (SUPN) stock price quote, stock graph, news & analysis.
23 Mar 2020 Real-time trade and investing ideas on Supernus Pharmaceuticals, Inc. SUPN from the largest community of traders and investors.
52 Week Low. 15.12. Shares Out (MIL) Price To Earnings (TTM). 7.77. Price To Supernus Pharma's ADHD treatment fails to impress; shares fall. Supernus
Oct 22, 2019 · Supernus Pharmaceuticals Inc. historial options data by MarketWatch. View SUPN option chain data and pricing information for given maturity periods.
Supernus Pharmaceuticals Inc. - NASDAQ:SUPN - Stock Quote ...
SUPN Stock | SUPERNUS PHARMACEUTICALS Stock Price Today ... SUPN: Get the latest Supernus Pharmaceuticals stock price and detailed information including SUPN news, historical charts and realtime prices. Stock Information - Supernus Pharmaceuticals The Investor Relations website contains information about Supernus Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
SUPN Stock Summary. With a one year PEG ratio of 105.07, Supernus Pharmaceuticals Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 76.1% of US stocks. Supernus Pharmaceuticals, Inc. (SUPN) Stock Price, Quote ... Supernus Provides Business Update. Supernus Pharmaceuticals, Inc. (SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today provides a business update related to the COVID-19 situation. SUPN Stock Price Quote & News - Supernus Pharmaceuticals ... View the real-time SUPN price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Supernus Pharmaceuticals against related stocks people have also bought like BMY, EXEL, ABBV, and MU. 894 people own Supernus Pharmaceuticals on Robinhood on April 4, 2020.